Giancarlo Torquati

Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life

F. Pane, L. Luciano, A. Scortechini, 2021, Current medical research and opinion.